Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on April 26, 2023, to announce its financial results for the fiscal quarter ended April 1, 2023. This filing primarily serves to furnish the press release detailing these results, which is incorporated by reference. Investors should refer to the press release (Exhibit 99.1) for the specific financial performance, including revenue, earnings per share, and any segment-specific details for the reported quarter. While the 8-K itself does not contain the detailed financial figures, it formally disseminates the official earnings announcement. The content of the press release will provide insights into the company's operational performance, its financial condition, and potentially any forward-looking statements or guidance provided by management. Investors are encouraged to review this press release thoroughly to understand the company's recent performance and future outlook.
Key Highlights
- 1Thermo Fisher Scientific announced its financial results for the fiscal quarter ended April 1, 2023.
- 2The results were disseminated via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The 8-K filing date is April 26, 2023, and the event date is April 25, 2023.
- 4Investors must consult Exhibit 99.1 for the actual financial performance details of the quarter.
- 5The filing states that the information furnished is not considered 'filed' for purposes of Section 18 of the Exchange Act, except as expressly set forth in specific filings.
- 6The 8-K includes the Cover Page Interactive Data File in its exhibits.